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CLINICAL INQUIRIES
What is the appropriate diagnostic 
evaluation of fibroids?
E V I D E N C E - B A S E D A N S W E R
When evaluating potential fibroids, 
a reasonable first step is a sonogram
In the asymptomatic patient with an enlarged, irregu-
larly contoured uterus on routine exam, the differen-
tial includes fibroids, fibroids, and fibroids. My usual
next step is to get a sonogram. The test is noninva-
sive, well-tolerated by patients, and significantly less
expensive than the alternatives. It quickly and easily
gives a great deal of useful information regarding the
size, shape, consistency of the myometrium and the
endometrium, from which we can reassure the
patient regarding the benign natural history of this
finding, especially in the perimenopausal woman. If
the patient presents with symptoms of abnormal
bleeding, pelvic pressure, or adnexal findings on
exam, the review suggests that further workup may
be indicated. However, the sonogram remains a very
useful initial test even in this case.
Lynda DeArmond, MD 
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Although transvaginal sonography (TVS) has
inconsistent sensitivity (0.21–1.00) and specificity
(0.53–1.00), its cost-efficiency and noninvasiveness
make it the best initial test for ruling in fibroid 
disease (strength of recommendation [SOR]: B,
based on expert opinion, a systematic review, and
prospective studies). 
Sonohysterography (SHG) and hysteroscopy
have superior sensitivity, specificity, and more 
discriminating positive and negative likelihood
ratios for diagnosing fibroids than does TVS 
(SOR: B, systematic review). SHG is less painful,
less invasive, and more cost-effective than 
hysteroscopy (SOR: B; single, prospective 
comparative study and cost comparison). 
Magnetic resonance imaging (MRI) had com-
parable precision to TVS in a single study, but it is
too expensive to be a good initial test for fibroids
(SOR: C, expert opinion and an uncontrolled
prospective study). One study reported a strong
correlation between ultrasound and bimanual
examination (SOR: C, retrospective case review).
C L I N I C A L C O M M E N T A R Y
■ Evidence summary
Uterine myomas are usually diagnosed by
incidental visualization during pelvic sono-
graphy or bimanual palpation of an
enlarged, mobile uterus with irregular con-
tours.1 In a retrospective chart review of
obese and nonobese patients with known
uterine fibroids, clinical estimate of uterine
size by bimanual examination correlated
with both ultrasound fibroid sizing and
posthysterectomy pathology analysis.2
Additional diagnostic testing is indicated for
patients with suspected fibroids and abnor-
mal uterine bleeding, increased pelvic girth,
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C O N T I N U E D
With equivocal
sonogram 
findings, or with
abnormal uterine
bleeding or other
symptoms, further
workup with SHG
or hysteroscopy
may be indicated
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pelvic pressure contributing to urinary fre-
quency or constipation, or pelvic pain with
intercourse or other physical activity.3
TVS has high sensitivity for detecting
myomas in a uterus of <10-week size. The
use of high-frequency probes improves the
sensitivity for diagnosing small myomas,
although their precise location with respect
to the uterine cavity often remains uncer-
tain. Localization of fibroids in a larger
uterus or when there are many tumors is
limited.4 Also, TVS may fail to detect small
fibroids and subserosal myomas. A system-
atic review of 9 heterogeneous studies eval-
uating TVS found wide ranges for sensitiv-
ity and specificity (TABLE).5 The cost of
TVS is less than half of sonohysterography
or diagnostic hysteroscopy, based on
Medicare allowable pricing data.6
SHG uses an intrauterine saline con-
trast medium with transvaginal ultrasonog-
raphy. This office-based procedure is more
invasive than TVS but requires no anesthe-
sia. SHG is more sensitive and specific than
TVS in detecting submucous myomas and
focal endometrial lesions.7 In a prospective
study of 81 symptomatic patients, using a
gold standard of surgical pathology, SHG
demonstrated more discriminating positive
and negative likelihood ratios (LR+, LR–)
for detecting myomata than did TVS or
hysteroscopy.8 A prospective study of 56
symptomatic patients with a gold standard
of hysteroscopic or surgical pathology sim-
ilarly found SHG to be superior to TVS.7 In
a systematic review of 7 studies, SHG
demonstrated a clinically significant LR+ of
29.7. There was too much heterogeneity in
the data to calculate an LR– (TABLE).5
Hysteroscopy is as accurate but more
invasive than SHG in evaluating uterine
myomata. In a systematic review of 4 stud-
ies, hysteroscopy had a pooled LR+ of 29.4
for diagnosing fibroids. Due to study het-
erogeneity, a pooled LR– could not be cal-
culated.5 A prospective, blinded compara-
tive study of SHG and hysteroscopy for
diagnosing fibroids in 117 women found
SHG to have a higher failure rate (22% vs
6%) but a statistically significant lower
median pain score: 1.6 (interquartile range
0.48–3.03) vs 3.2 (1.58–5.18) (P<.001)—
than hysteroscopy.9 Failure of SHG was
most commonly due to cervical stenosis. 
In a double-blinded comparative study
of 106 consecutive premenopausal women
undergoing hysterectomy for benign rea-
sons, MRI and TVS detected myomas with
equal precision (TABLE). MRI is preferred in
cases for which exact myoma mapping is
necessary and those with multiple myomas
or large uteri who are scheduled for
advanced surgical procedures.4 MRI costs
up to twice as much as sonohysterography
or diagnostic hysteroscopy, when compar-
ing Medicare allowable pricing data.6
Recommendations from others
A 1994 American College of Obstetrics
and Gynecology (ACOG) bulletin stated
that uterine fibroids can be diagnosed with
95% certainty by examination alone.10
ACOG recommends augmenting physical
examination with ultrasonography in cases
involving obese women or when adnexal
pathology cannot be excluded based on
examination alone. This bulletin also
points out that routine ultrasonography
does not improve long-term clinical out-
comes for fibroids. A more recent bulletin
(2000) addressed management but not
evaluation or diagnosis of leiomyomas.11
A 2003 guideline from the Society of
Obstetrics and Gynecology of Canada rec-
ommends against routine ultrasonography,
since it rarely affects the clinical manage-
ment of uterine fibroids. However, it
emphasizes the importance of ruling out
underlying endometrial pathology in
women with abnormal uterine bleeding.12
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Summary Prospective, 56 pts, Prospective, 81 Double-blind, 106 Systematic review 117 women; SHG 
characteristics symptomatic, symptomatic premenopausal including 19 studies compared with
of trial gold standard pts, gold pts undergoing with significant outpatient 
hysteroscopy or standard of hysterectomy for heterogeneity hysteroscopy 
hysterectomy “clinical survey”  benign reasons (gold standard)
pathology or histopathology
TVS (9 studies)
Sensitivity 84.8 65 (43–84) 99 (92–100) 21–100
Specificity 79 94 (79–99) 91 (75–98) 53–100
PPV 82.4 96 (88–99)
NPV 82 97 (82–100)
LR+ 4.0 10 (2.6–4.1) 11 (3.0–50) 1.61–62.25
0.19 0.4 (0.2–0.7) 0.01 (0.11–0) 0.03–0.80
SHG (7 studies)
Sensitivity 94.1 91 (72–99) 57–100 85.2
Specificity 88.5 94 (79–99) 96–100 87.3
PPV 91.4 74.3
NPV 92 93.2
LR+ 8.2 15 (3.8–56) 29.7 (17.8–49.6) 6.7
LR_ 0.067 0.1 (0.02–0.4) 0.06–0.47 0.17
Hysteroscopy (4 studies)
Sensitivity 88 (62–98) 53–100
Specificity 94 (79–99) 97–100
LR+ 14 (3.5–52) 29.4 (13.4–65.3)
LR– 0.1 (0.04–0.5) 0.08–0.48
MRI
Sensitivity 99 (92–100)
Specificity 86 (71–94)
PPV 92 (83–97)
NPV 97 (85–100)
LR+ 7.1 (03.2–16.7)
LR– 0.012 (0.11–0)
Italicized values were not reported in the original studies, but calculated for this review. Numbers in parentheses represent 95% confidence levels.
LR+ = positive likelihood ratio (a value greater than 10 is clinically significant and the higher the value, the more helpful the test at ruling 
in the diagnosis); LR– = negative likelihood ratio (a value less than 0.1 is clinically significant and the lower the value, 
the more helpful the test at ruling out the diagnosis). 
PPV, positive predictive value; NPV, negative predictive value; TVS, transvaginal sonography; SHG, sonohysterography; MRI, 
magnetic resonance imaging.
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